Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Prevention/Epidemiology

Rhode Island: Quest Resumes for AIDS Vaccine

October 21, 2005

Miriam Hospital in Providence, one of six centers chosen to test a new HIV vaccine, seeks 20 people ages 18-50 who can commit to coming to the hospital about once a month for a year to test a new HIV vaccine. The National Institutes of Health-funded study involves a vaccine composed of fragments of HIV virus that are attached to a deactivated adenovirus. It is hoped that if the inoculated person is later exposed to HIV, the T-cells should be primed to fight it off. The vaccine has been shown to be safe in Phase I trials. Phase II trials will assess its ability to provoke an immune response. If so, Phase III will determine whether it prevents HIV.

Back to other news for October 21, 2005

Adapted from:
Providence Journal
10.13.2005; Felice J. Freyer


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More HIV News

Tools
 

Advertisement